Antirheumatic Disease Therapies for the Treatment of COVID ‐19: A Systematic Review and Meta‐analysis

ConclusionIn this systematic review and meta ‐analysis, hydroxychloroquine use was not associated with benefit or harm with regard to COVID‐19 mortality. The evidence supporting the effect of other antirheumatic disease therapies in COVID‐19 is currently inconclusive.

Source: Arthritis and Rheumatology - August 1, 2020 Category: Rheumatology Authors: Michael Putman, Yu Pei Eugenia Chock, Herman Tam, Alfred H.J. Kim, Sebastian E. Sattui, Francis Berenbaum, Maria I. Danila, Peter Korsten, Catalina Sanchez ‐Alvarez, Jeffrey A. Sparks, Laura C. Coates, Candace Palmerlee, Andrea Peirce, Arun Tags: FULL LENGTH Source Type: research